Janus Henderson Group
LMAT icon

Janus Henderson Group’s LeMaitre Vascular LMAT Stock Holding History

Janus Henderson Group’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.18M Buy
10,832
+2,422
+29% +$231K ﹤0.01% 1622
2025
Q4 		$682K Hold
8,410
– – ﹤0.01% 1876
2025
Q3 		$736K Hold
8,410
– – ﹤0.01% 1818
2025
Q2 		$698K Sell
8,410
-50,270
-86% -$4.2M ﹤0.01% 1793
2025
Q1 		$4.87M Sell
58,680
-8,046
-12% -$748K ﹤0.01% 893
2024
Q4 		$6.15M Buy
66,726
+15,892
+31% +$1.53M ﹤0.01% 843
2024
Q3 		$4.72M Sell
50,834
-5,268
-9% -$456K ﹤0.01% 910
2024
Q2 		$4.62M Buy
56,102
+372
+0.7% +$27.3K ﹤0.01% 876
2024
Q1 		$3.7M Buy
55,730
+47,218
+555% +$2.91M ﹤0.01% 1000
2023
Q4 		$483K Sell
8,512
-16
-0.2% -$838 ﹤0.01% 2004
2023
Q3 		$465K Buy
8,528
+3
+0% +$178 ﹤0.01% 1958
2023
Q2 		$573K Sell
8,525
-10
-0.1% -$610 ﹤0.01% 1905
2023
Q1 		$439K Sell
8,535
-20,611
-71% -$1M ﹤0.01% 2087
2022
Q4 		$1.34M Sell
29,146
-2,112
-7% -$98.9K ﹤0.01% 1222
2022
Q3 		$1.58M Sell
31,258
-174
-0.6% -$8.7K ﹤0.01% 1121
2022
Q2 		$1.43M Buy
31,432
+5,726
+22% +$256K ﹤0.01% 1172
2022
Q1 		$1.2M Sell
25,706
-7,140
-22% -$320K ﹤0.01% 1419
2021
Q4 		$1.65M Buy
32,846
+2,951
+10% +$153K ﹤0.01% 1326
2021
Q3 		$1.59M Sell
29,895
-3,959
-12% -$223K ﹤0.01% 1297
2021
Q2 		$2.07M Sell
33,854
-4,356
-11% -$231K ﹤0.01% 1231
2021
Q1 		$1.86M Buy
38,210
+9,509
+33% +$446K ﹤0.01% 1192
2020
Q4 		$1.16M Buy
28,701
+2,920
+11% +$104K ﹤0.01% 1189
2020
Q3 		$839K Buy
25,781
+1,971
+8% +$59.2K ﹤0.01% 1158
2020
Q2 		$629K Buy
23,810
+11,562
+94% +$302K ﹤0.01% 1169
2020
Q1 		$305K Sell
12,248
-649,933
-98% -$20.1M ﹤0.01% 1226
2019
Q4 		$23.8M Sell
662,181
-6,513
-1% -$225K 0.01% 784
2019
Q3 		$22.9M Buy
668,694
+2,799
+0.4% +$89.4K 0.01% 796
2019
Q2 		$18.6M Sell
665,895
-5,982
-0.9% -$166K 0.01% 811
2019
Q1 		$20.8M Sell
671,877
-280
-0% -$7.47K 0.01% 783
2018
Q4 		$15.9M Sell
672,157
-19,124
-3% -$522K 0.01% 803
2018
Q3 		$26.8M Sell
691,281
-389
-0.1% -$14K 0.01% 743
2018
Q2 		$23.2M Buy
691,670
+87,197
+14% +$3.1M 0.01% 767
2018
Q1 		$21.9M Sell
604,473
-8,526
-1% -$295K 0.01% 777
2017
Q4 		$19.5M Buy
612,999
+418,108
+215% +$14.3M 0.01% 770
2017
Q3 		$7.29M Buy
194,891
+45,586
+31% +$1.55M ﹤0.01% 915
2017
Q2 		$4.66M Buy
+149,305
New +$4.31M ﹤0.01% 996

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Janus Henderson Group's LMAT Position: Q1 2026 in Review

Janus Henderson Group increased its LeMaitre Vascular (LMAT) stake by 29% in Q1 2026, buying an estimated $231K and bringing the position to 10,832 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #1622.

Janus Henderson Group first reported a position in LMAT in Q2 2017 and has held it in 36 quarters since. The position peaked at $26.8M in Q3 2018. 340 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Janus Henderson Group held 10,832 shares of LeMaitre Vascular worth $1.18M as of Q1 2026.
  • Janus Henderson Group bought 2,422 LeMaitre Vascular shares in Q1 2026, an estimated $231K.
  • LeMaitre Vascular made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #1622 holding.
  • Janus Henderson Group first reported a position in LeMaitre Vascular in Q2 2017 and has held it in 36 quarters since.
  • Janus Henderson Group's LeMaitre Vascular position peaked at $26.8M in Q3 2018.
  • 340 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.